Figure 11
From: A multi-compartment pharmacokinetic model of the interaction between paclitaxel and doxorubicin
Blind docking of paclitaxel and doxorubicin to CYP3A4. The blind docking illustration of paclitaxel (A) and doxorubicin (B) to CYP3A4. The red areas are the favorable binding regions and the blue areas are less favorable.
